logo
Many of Dead Sea scrolls may be older than thought, experts say

Many of Dead Sea scrolls may be older than thought, experts say

Yahoo2 days ago

Many of the Dead Sea scrolls could be older than previously thought, with some biblical texts dating from the time of their original authors, researchers say.
The first of the ancient scrolls were discovered in the caves of Qumran in the Judean desert by Bedouin shepherds in the mid-20th century. The manuscripts range from legal documents to parts of the Hebrew Bible, and are thought to date from around the third century BCE to the second century CE.
Now researchers have used artificial intelligence to glean fresh insights into the dates of individual scrolls – findings experts suggest could challenge ideas about when, where and by whom they were produced.
'It's like a time machine. So we can shake hands with these people from 2,000 years ago, and we can put them in time much better now, said Prof Mladen Popović, first author of the research from the University of Groningen in the Netherlands.
While some scrolls were radiocarbon dated in the 1990s, Popović said scholars did not tackle the problem of castor oil contamination – a substance applied in the 1950s to help experts read the manuscripts, but which could skew results.
In addition, many of the scrolls had only been dated by handwriting analysis.
Writing in the journal Plos One, the team report how they attempted radiocarbon dating of 30 samples from different manuscripts found at four sites and thought to span five centuries. Crucially, the team first cleaned the samples to remove the castor oil contamination.
The researchers successfully radiocarbon-dated 27 samples, finding that while two were younger than handwriting analysis had suggested, many were older.
Among other findings, the researchers discovered two different writing styles, known as Hasmonean and Herodian scripts, coexisted for a much longer period than previously thought, while a sample from a manuscript called 4Q114 – which contains verses from the book of Daniel – was older than traditional palaeography had suggested.
'It was previously dated to the late second century BCE, a generation after the author of the Book of Daniel. Now, with our study we move back in time contemporary to that author,' said Popović.
The team then used a type of AI known as machine learning to build a model they called Enoch – a nod to a biblical figure associated with scientific knowledge.
The team trained Enoch by feeding it 62 digital images of ink traces from 24 of the radiocarbon dated manuscripts, together with the carbon-14 dates.
They then verified the model by showing Enoch a further 13 images from the same manuscripts. In 85% of cases the model produced ages that tallied with the radiocarbon dates, and in many cases produced a smaller range of probable dates than obtained from radiocarbon dating alone.
'What we have created is a very robust tool that is empirically based – based on physics and on geometry,' said Popović.
When Enoch was presented with images from 135 undated manuscripts it had not previously seen, it realistically dated 79% of them – as judged by expert palaeographers. Popović added those deemed unrealistic might have had problematic data, such as poor quality images.
The system has already produced new insights including that a copy of the biblical book Ecclesiastes dates from the time of the book's presumed author.
Popović said Enoch meant the age of further scrolls could now be uncovered without radiocarbon dating – a process that requires the destruction of small samples.
'There are more than 1,000 Dead Sea scrolls manuscripts so our study is a first but significant step, opening a door unto history with new possibilities for research,' he said.
Prof emerita Joan Taylor of King's College London, said the results would have a major impact on Qumran studies.
'These results mean that most of the manuscripts found in the caves near Qumran would not have been written at the site of Qumran, which was not occupied until later,' she said.
However, Dr Matthew Collins of the University of Chester cautioned that radiocarbon dating only shed light on the age of the parchment, not when it was written on, while there were also questions about how stylistically representative the small number of training samples were for different periods in time.
'Overall, this is an important and welcome study, and one which may provide us with a significant new tool in our armoury for dating these texts,' he said. 'Nevertheless, it's one that we should adopt with caution, and in careful conjunction with other evidence.'

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Common menopause medication might prevent breast cancer while treating hot flashes
Common menopause medication might prevent breast cancer while treating hot flashes

Yahoo

time8 hours ago

  • Yahoo

Common menopause medication might prevent breast cancer while treating hot flashes

A drug intended to treat menopause symptoms could double as breast cancer prevention. New research from Northwestern University in Illinois found that Duavee, a Pfizer-made drug, "significantly reduced" breast tissue cell growth, which is a major indicator of cancer progression. A phase 2 clinical trial included 141 post-menopausal women who had been diagnosed with ductal carcinoma in situ (DCIS), also known as stage 0 breast cancer, according to a press release from Northwestern. Prostate Cancer Drug Now Available To More Patients With Aggressive Form Of Disease This non-invasive breast cancer affects more than 60,000 American women each year, often leading to an outcome of invasive breast cancer. The women were separated into two groups — one received Duavee and the other took a placebo for a month before undergoing breast surgery. Read On The Fox News App Duavee is a conjugated estrogen/bazedoxifene (CE/BZA) drug, which combines estrogen with another medication that minimizes the potential harmful side effects of the hormone. "The key takeaway from the study is that CE/BZA slows the growth (proliferation) of cells in milk ducts of DCIS that expressed the estrogen receptor significantly more than placebo," Dr. Swati Kulkarni, lead investigator and professor of breast surgery at Northwestern University Feinberg School of Medicine, told Fox News Digital. Experimental Women's Cancer Drug Boosts Survival Rates In Notable Study Another major finding is that the quality of life did not differ significantly between the two groups, but patients who took the CE/BZA reported fewer hot flashes during the study, she noted. "This would be expected, as the drug is FDA-approved to treat hot flashes." Kulkarni presented the study last week at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago. The findings are preliminary and have not yet been published in a medical journal. "What excites me most is that a medication designed to help women feel better during menopause may also reduce their risk of invasive breast cancer," said the doctor, who is also a Northwestern Medicine breast surgeon. Women who face a higher risk of breast cancer — including those who have experienced "high-risk lesions" — and who also have menopausal symptoms are most likely to benefit from the drug, according to Kulkarni. "These women are typically advised against standard hormone therapies, leaving them with few menopausal treatment options," the release stated. The researchers said they are "encouraged" by these early results, but more research is required before the medication can be considered for approval as a breast cancer prevention mechanism. "Our findings suggest that CE/BZA may prevent breast cancer, but larger studies with several years of follow-up are needed before we would know this for sure," Kulkarni told Fox News Digital. Dr. Sheheryar Kabraji, chief of breast medicine at the Roswell Park Comprehensive Cancer Center in Buffalo, New York, was not involved in the study but commented on the findings. "While intriguing, this study is highly preliminary, and more research will be needed before we can conclude that conjugated estrogen/bazedoxifene (CD/BZA), a form of the hormone estrogen commonly prescribed to address symptoms of menopause, prevents invasive breast cancer or is effective at reducing cancer risk," she told Fox News Digital. Click Here To Sign Up For Our Health Newsletter Kabraji also noted that the study focused on reducing levels of one specific protein, "which does not always predict reduced recurrence of breast cancer." "This study did not directly show that CE/BZA treatment reduces the risk of DCIS recurrence or development of invasive cancer," she noted. "Importantly, however, patients who received this therapy experienced no worsening of quality of life, and saw improvement in vasomotor symptoms, such as hot flashes. If found to be effective in preventing breast cancer, CE/BZA is likely to have fewer side effects than current medications used for breast cancer prevention." For more Health articles, visit Lead researcher Kulkarni emphasized that this medication is not for the treatment of invasive breast cancer or DCIS. "Right now, we can say that women who are concerned about their risk of developing breast cancer can consider this medication to treat their menopausal symptoms," she article source: Common menopause medication might prevent breast cancer while treating hot flashes

Avicenna.ai scoops CE marks for two AI fracture detection tools
Avicenna.ai scoops CE marks for two AI fracture detection tools

Yahoo

time15 hours ago

  • Yahoo

Avicenna.ai scoops CE marks for two AI fracture detection tools

French artificial intelligence (AI)-based medical imaging company has secured CE marks for a pair of radiologic screening tools to detect fractures from CT scans. CINA-VCF Quantix is an AI algorithm is used to detect unsuspected vertebral compression fractures (VCFs) in patients undergoing CT scans for unrelated conditions, while CINA-CSpine is designed for the detection and triage of cervical spine fractures. Both tools gained 510(k) clearance from the US Food and Drug Administration (FDA) in 2024, while the tools' receipt of CE mark follows clearance on five other AI tools in 2024 under the EU's Medical Device Regulation (EU MDR). For use in patients aged 50 and above who are undergoing patients undergoing CT scans of the chest or abdomen for other conditions, CINA-VCF Quantix automatically labels vertebrae and calculates vertebral height loss ratios in the thoracic and lumbar spine. In cases where a vertebral height loss ratio exceeds 20%–25%, a figure indicative of a moderate- to severe VCF, the algorithm generates prompts notifying radiologists to report their early findings in support of proactive patient care, Avicenna stated. co-founder and CEO, Cyril Di Grandi commented: "Osteoporotic vertebral fractures can have a profound impact on patients' quality of life. "By encouraging the reporting of VCF presence and severity, CINA-VCF Quantix has the potential to make a real difference in long-term patient outcomes." CINA-CSpine is designed to automatically flag suspected acute cervical spine fractures through radiologists' existing systems. Di Grandi continued: "The launch of CINA-CSpine in the European market marks a significant step forward in trauma care. By reducing the time between scan and diagnosis, we're helping radiologists catch cervical spine fractures faster and more reliably.' A 2023 report on AI in healthcare by GlobalData forecasts that global revenue for AI platforms across the sector will reach a valuation of almost $19bn by 2027, with the radiology field seeing some of the highest implementation of AI technologies. Research indicates that thoracolumbar fusion procedures, one of the most common spine surgery types, are in growing demand, with thoracolumbar procedures such as anterior lumbar interbody fusion (ALIF) and posterior lumbar fusion (PLF) in the US projected to see respective rises from 46,903 to 55,528 and 248,416 to 297,994 between 2020 and 2040. According to GlobalData, the spinal fusion market segment, of which thoracolumbar fusion is a part, is growing at a CAGR of 2.3% and forecast to reach a valuation of around $11.23bn by 2033. " scoops CE marks for two AI fracture detection tools" was originally created and published by Medical Device Network, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Errore nel recupero dei dati Effettua l'accesso per consultare il tuo portafoglio Errore nel recupero dei dati Errore nel recupero dei dati Errore nel recupero dei dati Errore nel recupero dei dati

Dead Sea Scrolls could be even older than previously thought, according to new study
Dead Sea Scrolls could be even older than previously thought, according to new study

Fox News

timea day ago

  • Fox News

Dead Sea Scrolls could be even older than previously thought, according to new study

Print Close By Andrea Margolis Published June 05, 2025 The Dead Sea Scrolls may be even older than researchers thought, according to a new study driven by an artificial intelligence (AI) model. A group of researchers from the Netherlands, Italy and Denmark recently published their findings in the journal PLOS One on June 4. The researchers said they developed an AI-based date-prediction model named Enoch, a nod to the biblical patriarch of the same name. ANCIENT CHRISTIAN FIGURINES DISCOVERED IN 1,500-YEAR-OLD DESERT GRAVES Enoch "was trained as a machine learning-based date-prediction model applying Bayesian ridge regression on established handwriting-style descriptors," according to the study. In order to date the scrolls, the model analyzed each one's handwriting style. Researchers also integrated radiocarbon dating methods — and found that most of the scrolls were at least a generation older than previously thought. Previous estimates placed the scrolls between 150 and 50 B.C., but the model found that many of the scrolls date to around 200 B.C. "There are no compelling paleographic or historical reasons that preclude these older dates as reliable time markers." "Enoch's style-based predictions are often older than traditionally assumed paleographic estimates, leading to a new chronology of the scrolls and the re-dating of ancient Jewish key texts that contribute to current debates on Jewish and Christian origins," the paper states. LITTLE GIRL DISCOVERS 3,800-YEAR-OLD AMULET WITH TIES TO BIBLICAL PEOPLE DURING FAMILY TRIP The researchers also indicate that the new dates are "realistic." "There are no compelling paleographic or historical reasons that preclude these older dates as reliable time markers," the authors said. For more Lifestyle articles, visit The scrolls, found in desert caves near the Dead Sea in the 1940s and 1950s, date between the third century B.C. to the first century A.D. They offer a wealth of knowledge about ancient Judaism, with many religious texts during the Second Temple period that were previously unknown. CLICK HERE TO SIGN UP FOR OUR LIFESTYLE NEWSLETTER Since their discovery, the scrolls have attracted a great amount of interest from both scholars and the public at large. In 2021, Israeli researchers uncovered dozens of new Dead Sea Scroll fragments. CLICK HERE TO GET THE FOX NEWS APP In April, the Ronald Reagan Presidential Library showcased a special collection of eight ancient Jewish manuscripts as part of its exhibition on the Dead Sea Scrolls. Print Close URL

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store